| B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008 | 2729 | 2008 |
| Identification of a unique TGF-β–dependent molecular and functional signature in microglia O Butovsky, MP Jedrychowski, CS Moore, R Cialic, AJ Lanser, G Gabriely, ... Nature neuroscience 17 (1), 131-143, 2014 | 2490 | 2014 |
| Development of a multiple sclerosis functional composite as a clinical trial outcome measure GR Cutter, ML Baier, RA Rudick, DL Cookfair, JS Fischer, J Petkau, ... Brain 122 (5), 871-882, 1999 | 1419 | 1999 |
| Oral fingolimod (FTY720) for relapsing multiple sclerosis L Kappos, J Antel, G Comi, X Montalban, P O'Connor, CH Polman, T Haas, ... New England Journal of Medicine 355 (11), 1124-1140, 2006 | 1317 | 2006 |
| Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor V Rothhammer, ID Mascanfroni, L Bunse, MC Takenaka, JE Kenison, ... Nature medicine 22 (6), 586-597, 2016 | 1170 | 2016 |
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ... Annals of neurology 66 (4), 460-471, 2009 | 1027 | 2009 |
| Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ... Nature medicine 6 (10), 1167-1175, 2000 | 994 | 2000 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 938 | 2018 |
| Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis T Kuhlmann, V Miron, Q Cuo, C Wegner, J Antel, W Brück Brain 131 (7), 1749-1758, 2008 | 896 | 2008 |
| TLR signaling tailors innate immune responses in human microglia and astrocytes CS Jack, N Arbour, J Manusow, V Montgrain, M Blain, E McCrea, ... The Journal of Immunology 175 (7), 4320-4330, 2005 | 877 | 2005 |
| iPSC-derived human microglia-like cells to study neurological diseases EM Abud, RN Ramirez, ES Martinez, LM Healy, CHH Nguyen, ... Neuron 94 (2), 278-293. e9, 2017 | 861 | 2017 |
| Microglial control of astrocytes in response to microbial metabolites V Rothhammer, DM Borucki, EC Tjon, MC Takenaka, CC Chao, ... Nature 557 (7707), 724-728, 2018 | 824 | 2018 |
| Neuroblastoma× spinal cord (NSC) hybrid cell lines resemble developing motor neurons NR Cashman, HD Durham, JK Blusztajn, K Oda, T Tabira, IT Shaw, ... Developmental dynamics 194 (3), 209-221, 1992 | 806 | 1992 |
| Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ... Archives of neurology 58 (1), 65-70, 2001 | 667 | 2001 |
| Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ... Brain: a journal of neurology 121 (8), 1469-1477, 1998 | 615 | 1998 |
| Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica JL Bennett, C Lam, SR Kalluri, P Saikali, K Bautista, C Dupree, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 608 | 2009 |
| Imaging axonal damage of normal-appearing white matter in multiple sclerosis. L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ... Brain: a journal of neurology 121 (1), 103-113, 1998 | 602 | 1998 |
| Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled … L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ... Nature medicine 6 (10), 1176-1182, 2000 | 601 | 2000 |
| An updated histological classification system for multiple sclerosis lesions T Kuhlmann, S Ludwin, A Prat, J Antel, W Brück, H Lassmann Acta neuropathologica 133, 13-24, 2017 | 575 | 2017 |
| Comparison of polarization properties of human adult microglia and blood‐derived macrophages BA Durafourt, CS Moore, DA Zammit, TA Johnson, F Zaguia, MC Guiot, ... Glia 60 (5), 717-727, 2012 | 540 | 2012 |
